A Study Based on Whole-genome Sequencing Yields a Rare Variant at 8q24 Associated with Prostate Cancer

In Western countries, prostate cancer is the most prevalent cancer of men and one of the leading causes of cancer-related death in men. Several genome-wide association studies have yielded numerous common variants conferring risk of prostate cancer. Here, we analyzed 32.5 million variants discovered by whole-genome sequencing 1,795 Icelanders. We identified a new low-frequency variant at 8q24 associated with prostate cancer in European populations, rs188140481[A] (odds ratio (OR) = 2.90; P(combined) = 6.2 × 10(-34)), with an average risk allele frequency in controls of 0.54%. This variant is only very weakly correlated (r(2) ≤ 0.06) with previously reported risk variants at 8q24, and its association remains significant after adjustment for all known risk-associated variants. Carriers of rs188140481[A] were diagnosed with prostate cancer 1.26 years younger than non-carriers (P = 0.0059). We also report results for a previously described HOXB13 variant (rs138213197[T]), confirming it as a prostate cancer risk variant in populations from across Europe.

Citing Articles

Hereditary and Familial Traits in Urological Cancers and Their Underlying Genes.

Hemminki K, Kiemeney L, Morgans A, Ranniko A, Pichler R, Hemminki O Eur Urol Open Sci. 2024; 69:13-20.

PMID: 39314911 PMC: 11416669. DOI: 10.1016/j.euros.2024.08.011.

Comprehensive assessment of the genetic characteristics of small for gestational age newborns in NICU: from diagnosis of genetic disorders to prediction of prognosis.

Xiao H, Chen H, Chen X, Lu Y, Wu B, Wang H Genome Med. 2023; 15(1):112.

PMID: 38093364 PMC: 10717355. DOI: 10.1186/s13073-023-01268-2.

Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.

Wang A, Shen J, Rodriguez A, Saunders E, Chen F, Janivara R Nat Genet. 2023; 55(12):2065-2074.

PMID: 37945903 PMC: 10841479. DOI: 10.1038/s41588-023-01534-4.

Fusion Oncogenes in Patients With Locally Advanced or Distant Metastatic Differentiated Thyroid Cancer.

Ju G, Sun Y, Wang H, Zhang X, Mu Z, Sun D J Clin Endocrinol Metab. 2023; 109(2):505-515.

PMID: 37622214 PMC: 10795910. DOI: 10.1210/clinem/dgad500.

Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects.

Ito S, Liu X, Ishikawa Y, Conti D, Otomo N, Kote-Jarai Z Nat Commun. 2023; 14(1):4863.

PMID: 37612283 PMC: 10447511. DOI: 10.1038/s41467-023-39858-8.

References

Haiman C, Le Marchand L, Yamamato J, Stram D, Sheng X, Kolonel L . A common genetic risk factor for colorectal and prostate cancer. Nat Genet. 2007; 39(8):954-6. PMC: 2391283. DOI: 10.1038/ng2098. View

Tomlinson I, Webb E, Carvajal-Carmona L, Broderick P, Kemp Z, Spain S . A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet. 2007; 39(8):984-8. DOI: 10.1038/ng2085. View

Gudmundsson J, Sulem P, Manolescu A, Amundadottir L, Gudbjartsson D, Helgason A . Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet. 2007; 39(5):631-7. DOI: 10.1038/ng1999. View

Zheng S, Sun J, Cheng Y, Li G, Hsu F, Zhu Y . Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. J Natl Cancer Inst. 2007; 99(20):1525-33. DOI: 10.1093/jnci/djm169. View

Lichtenstein P, Holm N, Verkasalo P, Iliadou A, Kaprio J, Koskenvuo M . Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000; 343(2):78-85. DOI: 10.1056/NEJM200007133430201. View

Amundadottir L, Thorvaldsson S, Gudbjartsson D, Sulem P, Kristjansson K, Arnason S . Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med. 2005; 1(3):e65. PMC: 539051. DOI: 10.1371/journal.pmed.0010065. View

Gudmundsson J, Sulem P, Steinthorsdottir V, Bergthorsson J, Thorleifsson G, Manolescu A . Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet. 2007; 39(8):977-83. DOI: 10.1038/ng2062. View

Gudmundsson J, Sulem P, Gudbjartsson D, Jonasson J, Masson G, He H . Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet. 2012; 44(3):319-22. PMC: 3655412. DOI: 10.1038/ng.1046. View

Crowther-Swanepoel D, Broderick P, Di Bernardo M, Dobbins S, Torres M, Mansouri M . Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat Genet. 2010; 42(2):132-6. PMC: 5321238. DOI: 10.1038/ng.510. View

10.

Marchini J, Howie B, Myers S, McVean G, Donnelly P . A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet. 2007; 39(7):906-13. DOI: 10.1038/ng2088. View

11.

Amundadottir L, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson B . A common variant associated with prostate cancer in European and African populations. Nat Genet. 2006; 38(6):652-8. DOI: 10.1038/ng1808. View

12.

Zanke B, Greenwood C, Rangrej J, Kustra R, Tenesa A, Farrington S . Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet. 2007; 39(8):989-94. DOI: 10.1038/ng2089. View

13.

Olama A, Kote-Jarai Z, Giles G, Guy M, Morrison J, Severi G . Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet. 2009; 41(10):1058-60. DOI: 10.1038/ng.452. View

14.

Ewing C, Ray A, Lange E, Zuhlke K, Robbins C, Tembe W . Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med. 2012; 366(2):141-9. PMC: 3779870. DOI: 10.1056/NEJMoa1110000. View

15.

Gudmundsson J, Sulem P, Gudbjartsson D, Blondal T, Gylfason A, Agnarsson B . Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat Genet. 2009; 41(10):1122-6. PMC: 3562712. DOI: 10.1038/ng.448. View

16.

Haiman C, Patterson N, Freedman M, Myers S, Pike M, Waliszewska A . Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet. 2007; 39(5):638-44. PMC: 2638766. DOI: 10.1038/ng2015. View

17.

Kong A, Masson G, Frigge M, Gylfason A, Zusmanovich P, Thorleifsson G . Detection of sharing by descent, long-range phasing and haplotype imputation. Nat Genet. 2009; 40(9):1068-75. PMC: 4540081. DOI: 10.1038/ng.216. View

18.

Kutyavin I, Milesi D, Belousov Y, Podyminogin M, Vorobiev A, Gorn V . A novel endonuclease IV post-PCR genotyping system. Nucleic Acids Res. 2006; 34(19):e128. PMC: 1636472. DOI: 10.1093/nar/gkl679. View

19.

Yeager M, Orr N, Hayes R, Jacobs K, Kraft P, Wacholder S . Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet. 2007; 39(5):645-9. DOI: 10.1038/ng2022. View

20.

Easton D, Pooley K, Dunning A, Pharoah P, Thompson D, Ballinger D . Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007; 447(7148):1087-93. PMC: 2714974. DOI: 10.1038/nature05887. View